P ure orbital blowout fractures are commonly encountered in the context of facial trauma and refer to fractures of the orbital walls with preservation of the orbital rim. 1 Of these, the orbital floor is commonly involved due to the thin bone medial to the infraorbital groove. 1, 2 Two theories for the mechanism of orbital blowout fractures have been proposed: an increase in intraocular pressure as a result of posterior displacement of the globe (hydraulic theory) or a direct blow to the inferior orbital rim with force transmission from the more rigid infraorbital rim to the relatively weak orbital floor (buckling theory). 2 In addition, a recent study suggested that trauma directly to the globe predisposes a patient to a more posterior fracture while trauma to the rim demonstrates an anterior predilection. 3 Fractures of the orbit can cause a multitude of problems, in particular diplopia, 4 ocular muscle entrapment, 1 enophthalmos, 4 and psychological trauma. 5 Orbital floor blowout fractures can be repaired using different techniques and implant materials. [6] [7] [8] [9] Implant materials may be synthetic, and these synthetic implants can be either resorbable or permanent. The amount of empirical support for individual materials used for orbital floor fracture reconstruction differs, and no definite conclusion has been reached regarding the best material for orbital floor fracture repair. 10 There is a lack of standardized guideline or consensus with different surgeons having different preferences and practices that are each supported by varying amounts of research. 11, 12 Permanent implant materials such as titanium, porous polyethylene, silicone elastomers, or nylon foil provide good tensile strength, are readily available, and have a long track record in craniofacial reconstruction. [7] [8] [9] 13, 14 Bioresorbable implants such as copolymers of poly-L-lactic acid, poly-D-lactide, polydioxanone, and polycaprolactone (PCL) offer a good readily available alternative to nonresorbable implants. 15, 16 As they become more available and widely used in craniofacial reconstruction, a comparison of these implants to standard permanent implants is timely.
There have been few studies comparing the different types of implants for orbital blowout fractures, 14, [16] [17] [18] [19] and there have been only 2 studies looking at pure orbital floor blowout fractures. One study compared porous polyethylene and bioresorbable poly-L-lactic acid sheet 14 and another compared autogenous bone grafts and bioresorbable poly-L/DL-lactide (P[L/DL]LA) implants. 20 These studies looked only at 1 type of bioresorbable implant (poly-L-lactic acid) and did not include titanium implant, which many craniomaxillofacial and oculofacial surgeons consider as a standard permanent implant. Hence, the authors conducted a study to compare the clinical outcomes of pure orbital floor blowout fractures repaired with either bioresorbable or nonresorbable implants (including titanium implants) in a single tertiary institution over a 10-year period.
from January 2005 to December 2014. Main outcome measures included improvement in clinical findings of ocular motility, diplopia, and enophthalmos. Implant-related complications were collected from patients' case files for analysis. Written informed consent was obtained from all patients, and the study was conducted in accordance with the tenets of the Declaration of Helsinki as amended in 2008. Institutional Review Board approval was obtained (DSRB 2013/00751).
Preoperative CT scans of the orbit were conducted according to the image-guided surgery protocol (1 mm cuts with the gantry set at 0°) by Ang et al. 21 The authors divided the fractures into 3 groups based on the preoperative CT scan results: small (<13.3 mm), medium (13.3-20 .0 mm), and large (>20 mm). The average length of the orbital floor is approximately 40 mm, 22 and fractures that were less than 1/3 the size of the orbital floor were considered to be small while fractures between ½ and 1/3 the size of the orbital floor were considered medium sized. Large fractures were fractures larger than ½ the size of the orbital floor.
The choice of implant (bioresorbable or permanent) largely depended on patient, fracture, and surgeon factors. Small fractures in younger patients were more likely to be repaired with bioresorbable implants. Medium and large fractures were likely to be repaired with either bioresorbable or permanent implants. If the patient was likely to be involved in future trauma again, we would lean more toward using a permanent implant. For very large fractures (>25 mm), the authors were also more likely to use a permanent implant.
The size of the defect was confirmed using a Matrix Orbital (Synthes, Oberdorf, Switzerland) malleable retractor, and template implant measurement was also carried out ( Fig. 1) . Prolapse of orbital tissue was defined radiologically while entrapment required both radiologic evidence of prolapse and clinical evidence of ocular motility restriction and a positive forced duction test. During fracture repair, the authors assessed if there was prolapse of orbital tissue or extraocular muscle through the fracture defect. There were 4 surgeons in our study.
All patients underwent orbital fracture repair via a direct transconjunctival approach. The authors generally perform a canthotomy or cantholysis for very large or more posteriorly extending fractures for greater exposure and for maneuvering of larger implants in the orbital space. The fracture size and location were predicted based on preoperative CT. Sixteen patients (18.2%) had a lateral canthotomy and inferior cantholysis. For all cases of orbital floor fractures, the repair was done as follows. A preincision forced duction test was conducted in all patients, and restriction of motion was suggestive of inferior rectus entrapment. Dissection was either preseptal if a triplanar incision was used or postseptal if a direct forniceal transconjunctival incision was used, depending on surgeon preference. A periosteal incision was made along the anterior orbital rim and the periosteum was reflected to expose the orbital floor fracture. Entrapped tissue was freed from all edges of the fracture and elevated from the adjacent maxillary sinus cavity in the orbit. Care was taken to avoid damage to the infraorbital neurovascular bundle. The frequently encountered orbital branch of the infraorbital artery was identified, cauterized, and cut before posterior dissection to identify the posterior ledge. Likewise, in medium to large floor fractures, the structures of the inferior orbital fissure were identified, cauterized, and released to expose the entire orbital floor-lateral wall to medial wall, inferior rim to the posterior ledge. The authors ensured that the medial, lateral, and posterior edges of the fracture were clearly identified prior to insertion of the implant to ensure proper placement.
Forced duction test was performed postoperatively to confirm that the implant did not entrap any tissue. The periosteum and conjunctiva were closed with 6-0 vicryl (Ethicon, Johnson & Johnson, Somerville, NJ, U.S.A.) suture. Adjuvants used intraoperatively included the Brainlab system (Brainlab, Feldkirchen, Germany) or the Medtronic system (Medtronic, Minneapolis, MN, U.S.A.), which were used for intraoperative surgical guidance. Intraoperative image guidance was used mainly in more complex fractures (e.g., orbital fracture combined with other facial fractures) where the operation was performed in conjunction with the plastic surgery team. We monitored the optic nerve function of all patients. Patients were reviewed at the following intervals 1 day, 1 week, 1 month, 3 months, 6 months, 1 year, and 15-24 months.
Postoperative CT was done for all patients who underwent fracture repair to check on the implant postoperative. We performed late postoperative imaging as part of our protocol, mostly to confirm complete bone healing and complete resorption of the implant and to assure patients of the status of the implants after complete healing. Patients who had resorption of the implant on late postoperative imaging (Fig. 2C ) and clinically stable were discharged from follow up.
The authors compared the type of implant used and clinical outcome measures such as diplopia, enophthalmos, and restriction of 
RESULTS
Three hundred five orbits of 277 patients underwent an orbital fracture repair during the study period of 10 years. Of these, 176 (57.7%) were orbital blowout fractures, of which 88 were isolated orbital floor blowout fractures. Of the other orbital blowout fractures, 10 were isolated medial wall fractures and 78 were combined floor and medial wall fractures. Patient demographics and surgical data are listed in Table 1 .
Bioresorbable implants were used in 48 patients (54.5%) while 40 patients had permanent implants (45.5%). Nineteen (47.5%) of the 40 patients with permanent implants had a prefabricated anatomical titanium implant. The medial wing of the titanium anatomical plate was trimmed completely, or a minimal wedge was left for medial support. Eighteen (45.0%) patients had a porous polyethylene implant, 2 (5%) patients had a porous titanium mesh with porous polyethylene, and 1 (2.5%) patient had a silastic implant.
Of the 48 patients with bioresorbable implants, the majority (n = 31, 64.6%) had a P(L/DL)LA 85/15 implant, 10 (20.8%) had a P(L/ DL)LA 70/30 implant (PolyMax; Synthes, Oberdorf, Switzerland), 6 (12.5%) had a PCL implant, and 1 (2.1%) had a P(L/DL)LA 70/30 implant (MacroPore; Biosurgery, Inc., San Diego, CA, U.S.A.).
Preoperatively, fractures were classified as small (<13.3 mm), medium (13.3-20 .0 mm), and large (>20.0 mm). 22 The authors analyzed the fracture types and implant used for individual fracture types. Most of the small (66.6%) and large (63.0%) fractures were repaired with bioresorbable implants while 65.4% of the medium fractures were repaired with permanent implants (Table 3) . Despite bioresorbable fractures being used more frequently in large fractures, the average width (p < 0.001) and length (p = 0.117) of fractures repaired using permanent implants were still greater than that of fractures repaired using bioresorbable implants (Table 2) . Patients were discharged from follow up after confirmation of complete healing and implant resorption for patients with bioresorbable implants.
The authors compared the clinical outcomes at postoperative year 1.5 (POY 1.5) for both bioresorbable and permanent implants based on different fracture types and illustrated them in Table 3 . In both groups, few patients experienced residual diplopia, enophthalmos, or ocular motility limitation across fracture types. For the group with permanent implants, 2 patients experienced diplopia (within 30° of primary gaze) and 1 patient experienced ocular motility limitation at POY1.5. Conversely, 1 patient experienced ocular motility limitation at POY1.5 for the group with resorbable implants. All patients had a free forced duction at the conclusion of surgery. It should be noted that the ocular motility observed postoperatively may be due to other causes such as muscle ischemia, rather than an implant-related complication. There were no significant differences in clinical outcomes at POY1.5 between both groups for all fracture types. *May have diplopia in more than 1 direction of gaze. †Enophthalmos defined as backward displacement of more than 2 mm compared with normal side. ‡May have ocular mobility limitation in more than 1 direction. §Excluding 1 default case from POM1 analysis, 15 cases from POM6 analysis, 36 cases from POY1 analysis, and 59 cases from POY 1.5 analysis. Many of these patients were foreign workers involved in industrial Table 4 compares the preoperative and postoperative clinical outcomes at various follow-up times for all patients and for the subgroups of bioresorbable and permanent implants. There was significant improvement in diplopia, enophthalmos, and ocular motility limitation postoperatively in all implant types (p < 0.05). This improvement was sustained with postoperative follow up. The authors also compared the clinical outcomes of patients with PCL implants with patients with P(L/DL)LA implants and found the clinical outcomes to be comparable at POY1.5 (Table 5) . Implant-related complications have been summarized in Table 6 . One patient with a titanium mesh with porous polyethylene implant had orbital compartment syndrome with raised intraocular pressure secondary to orbital hemorrhage which subsequently resolved with medical therapy. While palpable plates and screws are a reported complication with permanent implants, none of the patients in this series had this complication. There were no complications of postoperative blindness in their study.
Structure may not always correlate with function in the reconstruction of orbital fracture. A well-positioned, suitably sized implant would likely result in good clinical outcomes. The converse does not always hold true. In their study, the authors found that while some patients had suboptimal implant positioning or sizing, they still had good clinical outcomes. For example, 1 patient who had an inappropriately large implant (Fig. 3A) had no functional impairments postoperatively and at subsequent follow ups. In addition, rarely and not in this study, some patients with well-positioned implants on CT imaging may have suboptimal clinical outcomes.
DISCUSSION
Precise reconstruction of the orbit is necessary to avoid functional deficits and for restoration of anatomical relations and cosmesis. The choice of implant material contributes significantly to the long-term success of orbital reconstruction.
Titanium is a commonly used manufactured nonresorbable material for the reconstruction of craniomaxillofacial fractures as it provides stiffness and strength to avert buckling at the injury site and reduces fracture-site movement allowing for tissue repair to occur correctly. The malleability of titanium allows for presurgical contouring, and it is used for larger orbital floor defects. These implants have evolved from thin titanium meshes of the past to the anodized anatomical 3-dimensional prefabricated implants small (purple colored) and large (gold colored). Titanium meshes have also been associated with orbital adherence syndrome. 23 This has been overcome with the more recently available anodized thicker anatomical 3-dimensional prefabricated orbital titanium implants. Titanium implants are nonresorbable and remain as a permanent foreign body, with the persistent risk of complications. 24 In addition, they are not as easily positioned and the irregular edges of the mesh may catch prolapsed orbital fat. Thus, the advantages of the newer titanium plants include anatomical 3-dimensional reconstruction of orbits, relative customization of the implant to the deformity, and radiologic visibility.
Porous polyethylene implants have been the implant of choice of oculoplastic surgeons in western nations. 25 The open porous structure of the material allows for vascularization that creates the potential to transport cellular products and reduces the risk of implant migration. 26, 27 Due to its nonresorbable nature, there is a potential lifelong risk of infection and inflammation around the implant 28 although such cases are rare. Porous polyethylene is also easy to use as it does not require 
1.
Titanium mesh with porous polyethylene Secondary orbital hemorrhage resulting in raised IOP and orbital compartment syndrome. The impervious nature of porous polyethylene resulted in the formation of a collection of blood. The patient's IOP returned to normal following medical treatment with IV acetazolamide, topical brimonidine, and timolol. 2.
Titanium mesh orbital mesh plate Reoperation due to malposition of titanium implant that was noted on the CT scan at postoperative day 1 (Fig. 3B) . The medial aspect of the implant was inferior to the orbital wall. 3.
P(L/DL)LA 85/15 Patient reported upgaze restriction at postoperative month 6 follow-up review. CT scan revealed a malpositioned implant that was too small for the fracture (Fig. 2B) . Patient was treated conservatively and upgaze restriction resolved by POY1.
the fixation with screw and sutures although implant migration can occur until the device is fixed by the ingrowth of fibrous tissue. The silicone coating serves as a barrier sheet. The barrier sheet allows orbital contents to move and reduces incidences of orbital adherence. Disadvantages of the barrier sheet include the preclusion of the implant from integrating with the orbit. The impervious nature of the barrier sheet could also result in orbital compartment syndrome due to fluid accumulation postoperatively 29 and implant infection through the formation of a pseudocapsule allowing for abscess formation. 30 Bioresorbable implants degrade after the healing of the fracture through hydrolysis. 15 The key advantages of bioresorbable implants are that they promote the gradual transfer of functional forces to healing bone during their disintegration and provide mechanical integrity while the polymer resorbs. Properties include thermolability (P[L/DL]LA), contourability (P[L/DL]LA), and porosity (PCL). Contourability is an important characteristic given the precise nature of orbital floor reconstruction. 15 Biodegradable graft materials used in the internal orbit are mainly polymers comprising poly-L-lactic acid, poly-D-lactide, poly(L-lactide-co-glycolide), polydioxanone, and PCL in their pure form or in varying combinations with one another.
11 Poly(L-lactide-co-glycolide) is more susceptible to hydrolysis when compared with PCL, with poly(Llactide-co-glycolide) having a shorter lifespan and expected to fully degrade by around 12 months, while PCL is expected to fully degrade by 24 months.
14 Early scans showed the implant clearly ( Fig. 2A) . The implants were seen as isodense (PCL) to hyperdense (P[L/DL]LA) plates. In their study, bioresorbable implants were no longer seen on late postoperative CT scans after 15 to 24 months (Fig. 2C) . Based on late postoperative CT scans, orbital volume and orbital symmetry could be satisfactorily restored with bioresorbable implants (Fig. 2C) . In addition, not all bioresorbable implants are equally thermolabile. PCL has a melting point of 55°C and is typically not contoured by heating for orbital fractures, whereas that for P(L/DL)LA is higher and is usually contoured 3-dimensionally by heating to 65°C.
14 Based on their experience, usage of a water bath with very high temperatures on PCL during surgery would not be appropriate for the same reason. A comparison of the various implants including their advantages and disadvantages is shown in Table 7 .
Despite the rising popularity of bioresorbable implants since its first use in craniomaxillofacial surgery in the 1990s, there have been few studies published that directly compare bioresorbable implants to other types of implants. As such, it is difficult to draw formal and objective conclusions as to which material is best suited for orbital fracture repair.
Most importantly, the authors found that the clinical outcomes of diplopia, enophthalmos, and ocular motility restriction associated with the use of resorbable implants were comparable to that of nonresorbable implants. Han et al. compared the clinical outcomes of 331 patients with orbital blowout fractures repaired with either P(L/DL)LA 70/30 (MacroPore) or porous polypropylene and found that there was no difference in the degree of preoperative and postoperative diplopia, ocular motility limitation, and enophthalmos in the 2 groups. 18 Another study by Baek et al. comparing the clinical outcomes of 78 patients with blowout fractures who were treated with either titanium or absorbable mesh plate had similar findings. 17 The reservations that many surgeons have with the use of bioresorbable implant stem from studies that have associated resorbable implants with enophthalmos. These studies have reported that following the thorough resorption of the resorbable implants, the fibrosis and connective tissue that remain do not provide sufficient support resulting in enophthalmos. 31, 32 Their study found that enophthalmos improved in most patients, and at POY1.5, none of the patients who had bioresorbable implants had enophthalmos. The authors do acknowledge that with only 4 patients with preoperative enophthalmos in the bioabsorbable group, more evidence is needed before conclusions can be drawn in this regard. Nonetheless, most patients do not present with enophthalmos in the preoperative period due to periorbital edema, hence the number of patients is an underestimation of the patients who have enophthalmos. In addition, similar studies on bioresorbable implants had similar findings-that the prevalence of enophthalmos at long-term follow up in patients with bioresorbable implants for orbital floor fractures is similar to or even less than that of other nonresorbable implants. 14, 17, 33, 34 Their findings are similar to that of other studies which concluded that nonresorbable and resorbable implants were safe and reliable for the repair of orbital floor fractures. 15, 35, 36 Nonetheless, there is always concern that the intrinsic mechanical properties of biodegradable osteofixation systems are less favorable than those of titanium. While the authors demonstrated that bioresorbable implants were successfully used in all fracture sizes including fractures that are greater than 20 mm in their study, the average length and width of fractures were greater for permanent implants and might represent a preference for permanent implants in patients with extremely large orbital fractures. In addition, patients who are more prone to future trauma should consider having a permanent implant while younger patients would benefit more from a bioresorbable implant. Nonetheless, all patients should be given the option of bioresorbable or permanent implants and be counseled on the pros and cons of each. While surgeon preference also plays a role, the final choice should be made by the patient.
Limitations of our study include its retrospective nature. As a result, there were no defined criteria on implants to be used, and indications for each type of implant were not based on any fixed criteria of fracture size or type. Other factors such as the configuration and size of fracture or the surgeon's comfort level with a particular type of implant may have influenced the type of implant chosen. Finally, our patient numbers were also not as large as some other studies of orbital fractures as the authors were strict to include only pure orbital floor blowout fractures and excluded patients with combined fractures of other walls of the orbit or face.
In conclusion, their study has shown that the clinical outcomes achieved with the use of bioresorbable implants are comparable to that of traditional permanent implants for small, medium, and large orbital floor fractures. Therefore, both bioresorbable and permanent implants seem to be equally safe and effective for the treatment of patients with orbital floor blowout fractures. The advantages of bioresorbable implants include contourability and porosity, and patients with bioresorbable implants can be discharged when there is evidence of implant resorption 
